×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SRDX – surmodics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SRDX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/3
07:11 am
srdx
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries [Yahoo! Finance]
Low
Report
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries [Yahoo! Finance]
4/3
07:00 am
srdx
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries
Low
Report
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries
3/18
08:17 am
srdx
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now [Yahoo! Finance]
Low
Report
Here's Why You Should Retain Surmodics Stock in Your Portfolio Now [Yahoo! Finance]
3/10
09:43 am
srdx
FTC sues to block GTCR's ‘unlawful acquisition' of Surmodics [Yahoo! Finance]
Medium
Report
FTC sues to block GTCR's ‘unlawful acquisition' of Surmodics [Yahoo! Finance]
3/8
06:13 am
srdx
FTC challenges $627M private equity takeover of Surmodics [Yahoo! Finance]
Medium
Report
FTC challenges $627M private equity takeover of Surmodics [Yahoo! Finance]
3/7
08:40 am
srdx
Surmodics, Inc. (NASDAQ: SRDX) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating. They now have a $43.00 price target on the stock.
Low
Report
Surmodics, Inc. (NASDAQ: SRDX) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating. They now have a $43.00 price target on the stock.
3/6
09:00 pm
srdx
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
Low
Report
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
3/6
04:48 pm
srdx
US FTC sues to block private equity buy of medical company [Yahoo! Finance]
Low
Report
US FTC sues to block private equity buy of medical company [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/21
06:06 pm
srdx
Form SCHEDULE 13G/A SURMODICS INC Filed by: BARCLAYS PLC
Low
Report
Form SCHEDULE 13G/A SURMODICS INC Filed by: BARCLAYS PLC
3/19
04:01 pm
srdx
Form SCHEDULE 13D SURMODICS INC Filed by: GAMCO INVESTORS, INC. ET AL
Low
Report
Form SCHEDULE 13D SURMODICS INC Filed by: GAMCO INVESTORS, INC. ET AL
3/7
06:01 am
srdx
Form 8-K SURMODICS INC For: Mar 06
Medium
Report
Form 8-K SURMODICS INC For: Mar 06
2/18
05:23 pm
srdx
Form 4 SURMODICS INC For: Feb 13 Filed by: DANTZKER DAVID
Low
Report
Form 4 SURMODICS INC For: Feb 13 Filed by: DANTZKER DAVID
2/18
05:21 pm
srdx
Form 4 SURMODICS INC For: Feb 14 Filed by: BEDOYA JOSE H
Low
Report
Form 4 SURMODICS INC For: Feb 14 Filed by: BEDOYA JOSE H
2/14
02:47 pm
srdx
Form SCHEDULE 13G SURMODICS INC Filed by: BARCLAYS PLC
Low
Report
Form SCHEDULE 13G SURMODICS INC Filed by: BARCLAYS PLC
2/13
04:24 pm
srdx
Form SCHEDULE 13G/A SURMODICS INC Filed by: Beryl Capital Management LLC
Low
Report
Form SCHEDULE 13G/A SURMODICS INC Filed by: Beryl Capital Management LLC
2/10
12:00 pm
srdx
Form 8-K SURMODICS INC For: Feb 06
Low
Report
Form 8-K SURMODICS INC For: Feb 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/31
Q3/2019 6/30/2019 EPS 0.150 ZacksConsensus 0.050 ActVsEst 0.100 - Beat
12.6%
10/25 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.1%
8/28 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
3/25 Form SC 13G/A SURMODICS INC Filed by: Trigran Investments, Inc. 3.9%
2/5 Form 8-K SURMODICS INC For: Feb 05 3.8%
4/9 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 3.7%
8/19 SurModics, Inc. (NASDAQ: SRDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 2.9%
10/2 Form 4 SURMODICS INC For: Sep 30 Filed by: DANTZKER DAVID 2.7%
5/6 Form 8-K SURMODICS INC For: May 03 2.5%
5/1 SurModics (SRDX) Q2 2020 Earnings Call Transcript [The Motley Fool] 2.4%
10/25 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 6.1%
8/28 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.4%
3/25 Form SC 13G/A SURMODICS INC Filed by: Trigran Investments, Inc. 3.9%
2/5 Form 8-K SURMODICS INC For: Feb 05 3.8%
4/9 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 3.7%
8/19 SurModics, Inc. (NASDAQ: SRDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 2.9%
10/2 Form 4 SURMODICS INC For: Sep 30 Filed by: DANTZKER DAVID 2.7%
5/6 Form 8-K SURMODICS INC For: May 03 2.5%
5/1 SurModics (SRDX) Q2 2020 Earnings Call Transcript [The Motley Fool] 2.4%
TOP News Decliners
10/31
Q4/2019 9/30/2019 EPS 0.370 ZacksConsensus 0.350 ActVsEst 0.020 - Beat
-14.2%
6/5 Form 4 SURMODICS INC For: Jun 03 Filed by: Maharaj Gary R -6.7%
4/2 Form 4 SURMODICS INC For: Mar 31 Filed by: DANTZKER DAVID -4.6%
8/3 Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -4.5%
9/30 Form 4 SURMODICS INC For: Sep 26 Filed by: Arens Timothy J. -4.2%
12/10 Form SC 13G/A SURMODICS INC Filed by: Trigran Investments, Inc. -3.9%
11/5 Form 4 SURMODICS INC For: Nov 01 Filed by: Maharaj Gary R -3.8%
5/29 Surmodics to Present at Jefferies Healthcare Conference -3.7%
9/25 Form 4 SURMODICS INC For: Sep 23 Filed by: Stich Joseph J. -3.7%
9/9 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -3.6%
6/5 Form 4 SURMODICS INC For: Jun 03 Filed by: Maharaj Gary R -6.7%
4/2 Form 4 SURMODICS INC For: Mar 31 Filed by: DANTZKER DAVID -4.6%
8/3 Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -4.5%
9/30 Form 4 SURMODICS INC For: Sep 26 Filed by: Arens Timothy J. -4.2%
12/10 Form SC 13G/A SURMODICS INC Filed by: Trigran Investments, Inc. -3.9%
11/5 Form 4 SURMODICS INC For: Nov 01 Filed by: Maharaj Gary R -3.8%
5/29 Surmodics to Present at Jefferies Healthcare Conference -3.7%
9/25 Form 4 SURMODICS INC For: Sep 23 Filed by: Stich Joseph J. -3.7%
9/9 SurModics, Inc. (NASDAQ: SRDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: